Leprosy and AI: Do the Pros Outweigh the Cons?
Timothy Burton, Global Communications Lead at TLM International, shares his thoughts on the use of AI in the fight against leprosy.
- Phone: (011) 440 6323
- peter@tlm.co.za
Patient Story: How Fast does Multi-Drug Therapy Work?
A leprosy patient becomes non-infectious within 24 to 72 hours (just a few days) after taking their first dose of MDT.
In His Own Words: A Leprosy Patient’s Story
The following story is one of many we see on a regular basis, showing what a profound difference leprosy medication can make in the lives of our patients.
TLM Ambassador Attends the 4th International Training Program on Leprosy for Developing Countries
TLM ambassador Goodman Qhsoholo reports on the 4th International Training Program on Leprosy for Developing Countries.
People with First-Hand Experience in Leprosy take the Lead at Meetings in Kigali
Amar Timalsina reports on his recent trip to Kigali.
Last Mile Outcomes in Leprosy Care
Dr Arie de Kruijff explores some of the big issues in the fight against leprosy: “The obstruction is no longer medical.”
The Long Road to a Leprosy Vaccine
Why has LepVax taken decades to develop, while an effective Covid-19 vaccine took less than a year to create? Let’s look at the latest timeline.
Flood Relief Efforts: A Message from Nepal
A message from Amar at IDEA International, about the recent flood relief efforts in Nepal.
Encouraging News: How the Balance of Power is Shifting in the Leprosy and Disability Sectors
Five ways the balance of power is shifting in the leprosy and disability sectors.
How Community Health Volunteers are Making an Impact on Leprosy Diagnosis and Treatment
CHVs teach people in their communities how to detect early signs of leprosy, and how and when to access health services.